PATENT CLAIM ANALYSIS

Application Number: 16084451
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["514", "262100"]

Abstract:
Methods for treating diseases in which patients exhibit a reduced exercise capacity due to a decrease in their peripheral blood flow are provided, comprising administering an effective amount of tetrahydrobiopterin to the patient. The patient's resting blood flow is not affected by the administration, and smooth muscle dilating drugs may be administered to the patient concurrently with the tetrahydrobiopterin. Such diseases include chronic heart failure, peripheral vascular disease, diabetes and systemic sclerosis.

Claim (Index 5):
The method of  claim 1 , further comprising administration of at least one drug which causes constriction of the pulmonary blood vessels.

Metadata:
- Claim Count in Document: 43.0
- Percentile: 97.0
- Lexical Diversity: 1.33333
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14589324', '10563683', '13407118', '13017930', '11712404']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7380593818088946
- 35 USC 102 Novelty (BERT): 0.5071102204292584
- Combined Prediction Score: 0.7149644656709311
- Mean Citation Score: 226.018854
- Max Citation Score: 242.96014
- Similarity Product: 153.5134386591196

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test